These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Efficacy of oral tacrolimus on intestinal Behcet's disease. Matsumura K; Nakase H; Chiba T Inflamm Bowel Dis; 2010 Feb; 16(2):188-9. PubMed ID: 19504615 [No Abstract] [Full Text] [Related]
8. Successful treatment of steroid resistant ulcerative colitis associated with severe autoimmune hemolytic anemia with oral microemulsion cyclosporin--a brief case report. Molnár T; Szepes Z; Nagy F; Lonovics J Am J Gastroenterol; 2003 May; 98(5):1207-8. PubMed ID: 12809856 [No Abstract] [Full Text] [Related]
9. [Tacrolimus therapy for patients with ulcerative colitis]. Nakase H Nihon Shokakibyo Gakkai Zasshi; 2013 Nov; 110(11):1916-21. PubMed ID: 24189819 [No Abstract] [Full Text] [Related]
10. "Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis. Bousvaros A J Clin Gastroenterol; 2011 Jul; 45(6):479-80. PubMed ID: 21552139 [No Abstract] [Full Text] [Related]
11. Tacrolimus in the management of hospitalized patients with steroid-refractory ulcerative colitis: don't forget cytomegalovirus! Roblin X; Del Tedesco E Inflamm Bowel Dis; 2013 Apr; 19(5):E67-8. PubMed ID: 23314247 [No Abstract] [Full Text] [Related]
12. Calcineurin inhibition in severe ulcerative colitis: lost in translation? Annunziata ML; Hanauer SB Inflamm Bowel Dis; 2012 May; 18(5):809-11. PubMed ID: 21837776 [No Abstract] [Full Text] [Related]
13. Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. Taylor KM; Sparrow MP Aliment Pharmacol Ther; 2016 May; 43(9):1016-7. PubMed ID: 27040166 [No Abstract] [Full Text] [Related]
14. Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. Yamamoto T; Shimoyama T; Umegae S; Matsumoto K Aliment Pharmacol Ther; 2016 May; 43(9):1017-8. PubMed ID: 27040167 [No Abstract] [Full Text] [Related]
15. Tacrolimus plus ustekinumab in refractory ulcerative colitis. Latras Cortés I; Sierra-Ausín M Gastroenterol Hepatol; 2023 Feb; 46(2):148-149. PubMed ID: 35569545 [No Abstract] [Full Text] [Related]
16. Response to Roblin and Del Tedesco. Ogata H Inflamm Bowel Dis; 2013 Apr; 19(5):E68. PubMed ID: 23538853 [No Abstract] [Full Text] [Related]
17. Rectal tacrolimus in the treatment of resistant ulcerative proctitis. Lawrance IC; Copeland TS Aliment Pharmacol Ther; 2008 Nov; 28(10):1214-20. PubMed ID: 18761706 [TBL] [Abstract][Full Text] [Related]
18. The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor. Sayar E; Yucel A; Eisele B; Sayar EH; Glocker E; Yuksekkaya HA J Clin Gastroenterol; 2016 Apr; 50(4):352-3. PubMed ID: 26828243 [No Abstract] [Full Text] [Related]
19. Successful association in the treatment of pityriasis lichenoides et varioliformis acuta. Di Costanzo L; Balato N; La Bella S; Balato A J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):971-2. PubMed ID: 19175486 [No Abstract] [Full Text] [Related]
20. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis]. Ainsworth MA; Brynskov J Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]